Travus Therapeutics, Inc. — Form D

Travus Therapeutics, Inc. of Winston-Salem, NC, a company, filed a Form D exempt-offering notice with the SEC on 2016-07-12. The offering totals $2.3M, of which $750K was reported sold. Industry: Biotechnology.

Offering

• Filed: 2016-07-12
• Form: D
• Accession: 0001678007-16-000001
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $2.3M
• Amount sold: $750K
• Remaining: $1.5M
• Investors: 4
• Date of first sale: 2016-06-06
• Security types: debt
• Revenue range: Decline to Disclose
• SEC file number: 021-266753

Issuer

• Name: Travus Therapeutics, Inc.
• CIK: 0001678007
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2014
• Address: 101 N. Chestnut St., Suite 104, Winston-Salem, NC, 27101
• Phone: (760) 994-8020

Officers, directors & promoters (3)

More

• CIK 1678007 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search